## Abstract The majority of patients with systemic mastocytosis with associated clonal, hematological non‐mast cell lineage disease (SM‐AHNMD) have a myeloid stem cell malignancy including myelodysplastic syndromes (MDS), myelodysplastic/myeloproliferative disorders, acute myeloid leukemia (AML), o
Mast cell disease associated with acute myeloid leukemia: Detection of a new c-kit mutation Asp816His
✍ Scribed by Vinod A. Pullarkat; Sheeja T. Pullarkat; David C. Calverley; Russell K. Brynes
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 68 KB
- Volume
- 65
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
✦ Synopsis
Mast cell disease (MCD), a proliferation of mast cells (MC), is occasionally associated with hematologic malignancies. Neoplastic MC have activating c-kit mutations. c-kit is a receptor tyrosine kinase required for the development, proliferation, and survival of MC. Interaction of c-kit with its ligand stem cell factor induces dimerization, receptor phosphorylation, and signal transduction. The most common c-kit mutation detected in neoplastic MCD is Asp816Val, which results in ligand-independent autophosphorylation of the receptor leading to MC proliferation. We describe the rare occurrence of MCD associated with acute myeloid leukemia, report a novel c-kit mutation Asp816 His, and discuss the pathogenesis of MCD associated with hematologic malignancies.
📜 SIMILAR VOLUMES